# Aggressive Primary Cutaneous Apocrine Carcinoma of the Scalp: A Clinical Case Report

**Authors:** Elaheh Shaghaghian, David J Park, Krishna L Bharani, Subhro K Sen, Steven D. Chang

PMC · DOI: 10.7759/cureus.77444 · Cureus · 2025-01-14

## TL;DR

A rare case of aggressive scalp cancer originating from apocrine glands is reported, highlighting the challenges in diagnosis and treatment.

## Contribution

This case report presents a rare instance of scalp PCAC with recurrence and bone metastasis, emphasizing the need for aggressive treatment strategies.

## Key findings

- The patient had a history of PCAC with recurrence and bone metastasis six years after initial diagnosis.
- Molecular analysis revealed pathogenic alterations including HRAS G13R and FBXW7 Y545C.
- Successful surgical resection and reconstruction were performed for the neck apocrine carcinoma.

## Abstract

Primary cutaneous apocrine carcinoma (PCAC) is a rare malignancy originating from the apocrine glands of the skin. It is predominantly found in regions rich in apocrine glands, such as the axilla and anogenital area. Scalp involvement is rare, and the disease's aggressive behavior further complicates its management.

A 78-year-old male with a history of primary cutaneous apocrine carcinoma (PCAC) of the neck, previously managed with craniotomy, radiation, and chemotherapy, presented five years later with recurrence and bone metastasis. Six years after the initial diagnosis, he developed enlarging masses in the neck, necessitating extensive surgical resection. Histopathology confirmed primary cutaneous cribriform apocrine carcinoma with positive markers for CK7, GCDFP-15, EMA, and androgen receptors. Further molecular analysis performed on a fine-needle aspiration biopsy revealed pathogenic and likely pathogenic alterations, including HRAS G13R and FBXW7 Y545C. The patient underwent successful resection of the neck apocrine carcinoma by neurosurgeons, followed by soft tissue reconstruction by plastic surgeons.

This case highlights the importance and challenges of diagnosing and managing a scalp PCAC with recurrence and bone metastasis and the need for more aggressive follow-up and treatment strategies in similar cases.

## Linked entities

- **Genes:** HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265], FBXW7 (F-box and WD repeat domain containing 7) [NCBI Gene 55294]
- **Proteins:** KRT7 (keratin 7), PIP (prolactin induced protein), ETFA (electron transfer flavoprotein subunit alpha)

## Full-text entities

- **Genes:** KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, FBXW7 (F-box and WD repeat domain containing 7) [NCBI Gene 55294] {aka AGO, CDC4, DEDHIL, FBW6, FBW7, FBX30}, HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265] {aka C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, PIP (prolactin induced protein) [NCBI Gene 5304] {aka BRST-2, GCDFP-15, GCDFP15, GPIP4}
- **Diseases:** PCAC (MESH:D057091), malignancy (MESH:D009369), Scalp (MESH:D004476), bone metastasis (MESH:D009362), primary cutaneous cribriform apocrine carcinoma (MESH:D000230)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G13R, Y545C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11825106/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11825106/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC11825106/full.md

---
Source: https://tomesphere.com/paper/PMC11825106